NIDA T32 Training Program:
Postdoctoral Training in Drug Abuse Research
Behavior & Neurobiology

ARTT Center of Excellence

Current Trainees


Highslide JS
Brenda Gannon, Ph.D.
Dept. of Pharmacology
Collins Lab
gannonb@uthscsa.edu

As a member of the Collins laboratory, my research is aimed at understanding factors that mediate drug-taking and drug-seeking behaviors.
My current research uses behavioral and pharmacological assays such as intravenous self-administration, drug discrimination, and locomotor activity to investigate vulnerability to stimulant abuse and to evaluate potential treatments for drug abuse. This includes quantitative assessments of the abuse-related and toxic effects of common “bath salt” constituents (e.g., alpha-PVP, MDPV, and methylone) and comparisons to other well-known stimulant drugs of abuse (e.g., methamphetamine and cocaine).

Highslide JS
T. Lee Gilman, Ph.D.
Dept. of Pharmacology
Daws Lab
gilmant@uthscsa.edu

Coming Soon!

Highslide JS
Audrey Hager, Ph.D.
Dept. of Pharmacology
Beckstead Lab
hagera@uthscsa.edu

As a postdoctoral fellow in Michael Beckstead's Lab I research neuroplasticity in the midbrain and the role of dopamine neurons in addiction and Parkinson's disease.

Highslide JS
Vanessa Minervini, Ph.D.
Dept. of Pharmacology
France Lab
minervini@uthscsa.edu

Currently available pharmacotherapies for treating pain are not effective in some patients and have a number of unwanted and deleterious effects that preclude their use in other patients. My projects in Dr. France’s laboratory are exploring the therapeutic potential of various opioid-cannabinoid drug combinations. A primary goal of this research is to characterize the effects of the drug combinations on performance in complex memory and decision-making tasks before, during, and upon discontinuation of chronic treatment.

Highslide JS
Jessica Solis, Ph.D.
Dept. of Psychiatry
Dougherty Lab
SolisJ5@uthscsa.edu

My research interests revolve around the intergenerational transmission of stress and coping models that could help explain the intergenerational transmission of alcohol use within high-risk families. As a member of the Dougherty Lab, I am currently extending this work to further explore how impulse control and family histories of substance use disorders interact with the initiation and continuation of substance use in youth.

Highslide JS
Peter Weed, Ph.D.
Dept. of Pharmacology
France Lab
weedp@uthscsa.edu

Opioid analgesics are currently the primary treatment for chronic pain. However, therapeutic doses have several untoward side effects, including tolerance to the analgesic effects and physical dependence. Our laboratory has identified that co-administration of a cannabinoid agonist with an opioid can increase the analgesic effect, thus reducing the required dose. My projects in the France laboratory are exploring the therapeutic potential of these opioid-cannabinoid combinations. A primary goal of the research is to characterize the development of tolerance and dependence during chronic administration of opioid-cannabinoid combinations in an assay of analgesia.

The project described is supported by Award Number T32DA031115 from the National Institute On Drug Abuse. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute On Drug Abuse or the National Institutes of Health.